The role of cohort studies in drug development: Clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous system
Scott L. Letendre, Jennifer Marquie-Beck, Ronald J. Ellis, Steven Paul Woods, Brookie Best, David B. Clifford, Ann C. Collier, Benjamin B. Gelman, Christina Marra, Justin C. McArthur, J. Allen McCutchan, Susan Morgello, David Simpson, Terry J. Alexander, Janis Durelle, Robert Heaton, Igor Grant, Thomas D. Marcotte, Shondra Neumayer, Edmund CapparelliJ. Hampton Atkinson, Donald Franklin, Joseph K. Wong, Caroline Ignacio, Terry Jernigan, Michael J. Taylor, Rebecca Theilmann, Anthony C. Gamst, Clint Cushman, Michelle Frybarger, Ian Abramson, Deborah Lazzaretto, Rodney Von Jaeger, Muhammad Al-Lozi
Dive into the research topics of 'The role of cohort studies in drug development: Clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous system'. Together they form a unique fingerprint.